LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
LGVN Longeveron
- 1.520
- -0.010-0.65%
Close Feb 28 16:00 ET
- 1.830
- +0.310+20.39%
Post 20:01 ET
22.55MMarket Cap-0.27P/E (TTM)
1.560High1.450Low3.83MVolume1.530Open1.530Pre Close7.53MTurnover32.82%Turnover RatioLossP/E (Static)14.84MShares6.40052wk High0.88P/B17.75MFloat Cap0.77152wk Low--Dividend TTM11.68MShs Float450.000Historical High--Div YieldTTM7.19%Amplitude0.770Historical Low1.963Avg Price1Lot Size
Longeveron Stock Forum
Sign in to post a comment
TheFather's SureBet & LongTermSpecial, it took watching all day. Beautifully, $Longeveron (LGVN.US)$ the math worked!
ALWAYS TAKE PROFITS
ALWAYS TAKE PROFITS
9
8
1
Held and now taking profits
Once I have a deluted negative cost, I will hold.
The outlook is about 7.5 dollars, and the company has low debt
$Longeveron (LGVN.US)$
Once I have a deluted negative cost, I will hold.
The outlook is about 7.5 dollars, and the company has low debt
$Longeveron (LGVN.US)$
3
$Longeveron (LGVN.US)$ dude i cant believe this everything looked great, i buy 2.11 and i hold the bagss????? WHY
1
3
8
3
$Longeveron (LGVN.US)$
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
Friday, 28th February at 4:04 pm
Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ (laromestrocel) in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease and orphan-designated indication, has achieved more than 90% enrollment and is expected to complete enrollment in the second quarter of 2025
Lomecel-B™ Biological License Application (BLA) submission for ful...
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
Friday, 28th February at 4:04 pm
Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ (laromestrocel) in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease and orphan-designated indication, has achieved more than 90% enrollment and is expected to complete enrollment in the second quarter of 2025
Lomecel-B™ Biological License Application (BLA) submission for ful...
1
$Longeveron (LGVN.US)$
On its way today
Pain staking searches will always produce results. Patience is a virtue
1. My strategy is to find an item that has immediate results in order to sell and recuperate the initial investment by selling 50% of the initial shares purchased. (SureBet!)
2. Leaving the remaining 50% to hit as a limit sale at the obnoxious goal minus 20% for a safer bet. (Long-TermSpecial)
The Father of Stocks: Laying the groundwork for market an...
On its way today
Pain staking searches will always produce results. Patience is a virtue
1. My strategy is to find an item that has immediate results in order to sell and recuperate the initial investment by selling 50% of the initial shares purchased. (SureBet!)
2. Leaving the remaining 50% to hit as a limit sale at the obnoxious goal minus 20% for a safer bet. (Long-TermSpecial)
The Father of Stocks: Laying the groundwork for market an...
6
No comment yet
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!
ANESHA warren newbie : wow
ANESHA warren newbie : teach me
TheFather OP : Thank you!
ANESHA warren newbie TheFather OP : im serious
Deneven Rex : How many hours did it take you to do that crazy miraculous trade?
View more comments...